Louise Stanley, Author at PHTA Ltd

7 things biotech SMEs need to know about protecting and funding innovation

Guest blog by Sarah Picken, Director of S&W Group Sarah has over a decade of experience in supporting businesses fund their innovation through R&D and Patent Box incentives. She leverages her corporate tax background to take a holistic and future looking approach to incentives claim management. Biotech businesses are built on innovation. Whether you’re developing […]

Science Minister Lord Vallance visits Birmingham Health Innovation Campus

Science Minister Lord Vallance has visited Birmingham Health Innovation Campus (BHIC), a world-leading research hub for innovation at the heart of Birmingham’s health and life sciences district, which is home to PHTA. During the visit which followed the launch of a £50m Local Innovation Partnership Fund (LIPF), Lord Vallance met with the leaders of PHTA, the […]

Selling medtech to the NHS: what innovators need to know

Judith Stewart, Director of Economic, Commercial and Business Development at PHTA resident Health Innovation West Midlands, recently presented at the MedTech Innovation Expo Birmingham. She shared her insights on what it really takes to succeed as a medtech innovator selling into the NHS… The market is bigger than you think – but different to what […]

Building a regulatory pathway: PHTA partners with Maytal

The University of Birmingham’s Precision Health Technologies Accelerator (PHTA) has joined forces with Maytal, a global leader in regulatory consultancy, to support companies developing the next generation of medical devices and in vitro diagnostics. Maytal specialises in helping medtech companies navigate the complex landscape of product regulation, design and certification across the UK, EU, USA […]

Digital health founder advancing skin cancer monitoring technology at PHTA

Naevi, a digital health company developing a precision mole monitoring app to support earlier identification of skin cancer, has joined the PHTA community as it prepares to move into clinical validation. More than 16,000 new cases of melanoma are diagnosed in the UK each year. Survival is strongly linked to stage at diagnosis, meaning earlier […]

Osler Diagnostics and PHTA collaborate on usability study to advance point-of-care cardiac testing

Osler Diagnostics has partnered with the University of Birmingham’s Precision Health Technologies Accelerator (PHTA) to support the development of its Osler Origin® System, a novel diagnostic platform designed to deliver laboratory-quality testing directly at the location where patients receive care. The collaborative usability study will see Osler work with PHTA and its anchor resident, Clinical […]

Impli awarded £1.4M NIHR grant to advance world-first continuous hormone monitoring

The award will fund a 30-month consortium programme bringing together PHTA-based Impli, Imperial College Healthcare NHS Trust, King’s College London, and Fertility Europe to take the BEAM biosensor from prototype to first-in-human clinical validation. Impli, the deep-tech company developing the first continuous molecular monitoring platform for hormonal health at PHTA, has been awarded a £1.4 […]

PHTA and MedTech Makers Lab launch collaboration to bring global innovators to Birmingham

The University of Birmingham’s Precision Health Technologies Accelerator (PHTA) has established a strategic partnership with MedTech Makers Lab Ltd (MML) to bring high-potential, international medtech and life sciences companies into the West Midlands. The collaboration will see MML and PHTA work together to attract high-growth international companies into Birmingham’s health and life sciences district, supporting […]

£1.4 million secured for new PHTA cleanroom manufacturing facility

University Hospitals Birmingham (UHB) has secured £1.4 million from the National Institute for Health and Care Research (NIHR) to support the development of a new cleanroom manufacturing facility within PHTA. The 440 sq m facility will provide specialist capability for the preparation and early-stage manufacture of innovative medicines and advanced therapies for use in NHS […]

Pioneering health innovation in Birmingham: five minutes with our CEO

Ahead of the Greater Birmingham Chamber of Commerce Awards, where we’ve been shortlisted in the Pioneer category, we spoke to CEO Professor Gino Martini about the vision behind the facility, the partnerships that helped bring it to life, and its role in supporting the next generation of health and life sciences businesses in Birmingham. From […]

Connect With Us